Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gomez Barila, Patricia M."'
Autor:
Buikhuisen, Joyce Y.1,2 (AUTHOR), Gomez Barila, Patricia M.1,2 (AUTHOR), Cameron, Kate1,2 (AUTHOR), Suijkerbuijk, Saskia J. E.2,3 (AUTHOR), Lieftink, Cor2,4 (AUTHOR), di Franco, Simone5 (AUTHOR), Krotenberg Garcia, Ana2,3 (AUTHOR), Uceda Castro, Rebeca2,3 (AUTHOR), Lenos, Kristiaan J.1,2 (AUTHOR), Nijman, Lisanne E.1,2 (AUTHOR), Torang, Arezo1,2 (AUTHOR), Longobardi, Ciro1,2 (AUTHOR), de Jong, Joan H.1,2 (AUTHOR), Dekker, Daniëlle1,2 (AUTHOR), Stassi, Giorgio5 (AUTHOR), Vermeulen, Louis1,2 (AUTHOR), Beijersbergen, Roderick L.2,4 (AUTHOR), van Rheenen, Jacco2,3 (AUTHOR), Huveneers, Stephan6 (AUTHOR), Medema, Jan Paul1,2 (AUTHOR) j.p.medema@amsterdamumc.nl
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 3/4/2023, Vol. 42 Issue 1, p1-18. 18p.
Autor:
Buikhuisen, Joyce Y., Gomez Barila, Patricia M., Cameron, Kate, Suijkerbuijk, Saskia J. E., Lieftink, Cor, di Franco, Simone, Krotenberg Garcia, Ana, Uceda Castro, Rebeca, Lenos, Kristiaan J., Nijman, Lisanne E., Torang, Arezo, Longobardi, Ciro, de Jong, Joan H., Dekker, Daniëlle, Stassi, Giorgio, Vermeulen, Louis, Beijersbergen, Roderick L., van Rheenen, Jacco, Huveneers, Stephan, Medema, Jan Paul
Additional file 1: Supplementary Fig. S1. Validation of PAK2 as an essential kinase for CMS4 cell lines. A, PAK1–3 mRNA expression levels in a panel of 28 CRC cell lines, also including those used for the drop-out screen, as determined by quantitat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f572fd54fecc4c30ee7657d99d8f751
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joyce Y. Buikhuisen, Patricia M. Gomez Barila, Kate Cameron, Saskia J. E. Suijkerbuijk, Cor Lieftink, Simone di Franco, Ana Krotenberg Garcia, Rebeca Uceda Castro, Kristiaan J. Lenos, Lisanne E. Nijman, Arezo Torang, Ciro Longobardi, Joan H. de Jong, Daniëlle Dekker, Giorgio Stassi, Louis Vermeulen, Roderick L. Beijersbergen, Jacco van Rheenen, Stephan Huveneers, Jan Paul Medema
Publikováno v:
Journal of experimental & clinical cancer research, 42(1):56. BioMed Central
Background Colorectal cancer (CRC) can be divided into four consensus molecular subtypes (CMS), each with distinct biological features. CMS4 is associated with epithelial-mesenchymal transition and stromal infiltration (Guinney et al., Nat Med 21:135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8758ca399e1fd556a240ad9297fdc880
https://pure.amc.nl/en/publications/subtypespecific-kinase-dependency-regulates-growth-and-metastasis-of-poorprognosis-mesenchymal-colorectal-cancer(a8d716b3-6f3e-4132-b160-a4f299f23fe0).html
https://pure.amc.nl/en/publications/subtypespecific-kinase-dependency-regulates-growth-and-metastasis-of-poorprognosis-mesenchymal-colorectal-cancer(a8d716b3-6f3e-4132-b160-a4f299f23fe0).html
Autor:
Ronja S. Adam, Dennis Poel, Leandro Ferreira Moreno, Joey M. A. Spronck, Tim R. de Back, Arezo Torang, Patricia M. Gomez Barila, Sanne ten Hoorn, Florian Markowetz, Xin Wang, Henk M. W. Verheul, Tineke E. Buffart, Louis Vermeulen
Publikováno v:
Molecular Oncology, 16, 2693-2709
Molecular Oncology, 16, 14, pp. 2693-2709
Adam, R S, Poel, D, Ferreira Moreno, L, Spronck, J M A, de Back, T R, Torang, A, Gomez Barila, P M, ten Hoorn, S, Markowetz, F, Wang, X, Verheul, H M W, Buffart, T E & Vermeulen, L 2022, ' Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes ', Molecular oncology, vol. 16, no. 14, pp. 2693-2709 . https://doi.org/10.1002/1878-0261.13210
Molecular oncology, 16(14), 2693-2709. Elsevier
Molecular Oncology, 16, 14, pp. 2693-2709
Adam, R S, Poel, D, Ferreira Moreno, L, Spronck, J M A, de Back, T R, Torang, A, Gomez Barila, P M, ten Hoorn, S, Markowetz, F, Wang, X, Verheul, H M W, Buffart, T E & Vermeulen, L 2022, ' Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes ', Molecular oncology, vol. 16, no. 14, pp. 2693-2709 . https://doi.org/10.1002/1878-0261.13210
Molecular oncology, 16(14), 2693-2709. Elsevier
Funder: New York Stem Cell Foundation; Id: http://dx.doi.org/10.13039/100003194
Previously, colorectal cancer (CRC) has been classified into four distinct molecular subtypes based on transcriptome data. These consensus molecular subtypes (CMSs)
Previously, colorectal cancer (CRC) has been classified into four distinct molecular subtypes based on transcriptome data. These consensus molecular subtypes (CMSs)
Autor:
Gomez Barila PM, Medema JP
Publikováno v:
Oncoscience [Oncoscience] 2023 Jun 27; Vol. 10, pp. 24-26. Date of Electronic Publication: 2023 Jun 27 (Print Publication: 2023).
Autor:
Adam RS; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Poel D; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Ferreira Moreno L; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Spronck JMA; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., de Back TR; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Torang A; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Gomez Barila PM; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Ten Hoorn S; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Markowetz F; Cancer Research UK Cambridge Institute, University of Cambridge, UK., Wang X; Department of Biomedical Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong.; Shenzhen Research Institute, City University of Hong Kong, Shenzhen, China., Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Buffart TE; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Vermeulen L; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Jul; Vol. 16 (14), pp. 2693-2709. Date of Electronic Publication: 2022 Apr 29.